Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider

Clinical Therapeutics
Volume 43 Issue 2 p211-430, e33-e56
http://www.clinicaltherapeutics.com/current

 

Commentary
Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider
Manfred Hauben, Craig G. Hartford
Published online: January 18, 2021
Abstract
Artificial intelligence (AI), a highly interdisciplinary science, is an increasing presence in pharmacovigilance (PV). A better understanding of the scope of artificial intelligence in pharmacovigilance (AIPV) may be advantageous to more sharply defining, for example, which terms, methods, tasks, and data sets are suitably subsumed under the application of AIPV. Accordingly, this article explores relevant points to consider regarding defining the scope of AIPV and offers a potential working definition of the scope of AIPV.